Charles C. Duncan

CHARLES C. DUNCAN, PhD, CFA, is a Senior Biotechnology Analyst at
Prudential Vector Healthcare Group, covering genomics companies. He was
previously associated with Tucker Anthony Cleary Gull, Inc. where he was
Senior Vice President covering biotech and emerging pharmaceutical
companies. Dr. Duncan has passed Level I of the Chartered Financial
Analyst (CFA) program and he received a BS in Zoology from the
University of Wisconsin-Madison. and a PhD from the University of
Colorado in Pharmaceutical Sciences. JOHN S. SONNIER is a Senior
Biotechnology Analyst with the Prudential Vector Healthcare Group,
focusing on small, mid- and large cap companies in the areas of
infectious disease, transfusion medicine and neuroscience. He joined
Prudential Securities via the July 1999 acquisition of Vector Securities
International, Inc. Prior to joining Vector, Mr. Sonnier spent eight
years in the pharmaceutical industry at Johnson & Johnson and Baxter
and, most recently, as the Senior Healthcare Planning Manager at Baxter
Healthcare Corporation, Biotech Group. He received his BS degree in
Business from the University of Southern Mississippi.